Freedom Investment Management’s Rithm Capital RITM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,261
Closed -$230K 811
2024
Q3
$230K Buy
+20,261
New +$231K 0.02% 676
2021
Q3
Sell
-24,783
Closed -$262K 889
2021
Q2
$262K Buy
24,783
+1,028
+4% +$10.9K 0.02% 731
2021
Q1
$267K Buy
23,755
+1,287
+6% +$13.1K 0.02% 694
2020
Q4
$223K Sell
22,468
-6,723
-23% -$59.5K 0.02% 547
2020
Q3
$232K Sell
29,191
-4,320
-13% -$33.3K 0.03% 471
2020
Q2
$249K Buy
33,511
+2,339
+8% +$15.1K 0.03% 455
2020
Q1
$537K Sell
31,172
-18,046
-37% -$262K 0.05% 323
2019
Q4
$793K Buy
49,218
+3,248
+7% +$51K 0.07% 239
2019
Q3
$721K Sell
45,970
-834
-2% -$12.5K 0.06% 274
2019
Q2
$720K Buy
46,804
+849
+2% +$13.8K 0.06% 280
2019
Q1
$777K Sell
45,955
-17,152
-27% -$282K 0.06% 292
2018
Q4
$897K Sell
63,107
-16,180
-20% -$273K 0.07% 285
2018
Q3
$1.47M Buy
79,287
+113
+0.1% +$2.06K 0.09% 215
2018
Q2
$1.39M Buy
79,174
+69,170
+691% +$1.21M 0.08% 256
2018
Q1
$165K Buy
+10,004
New +$170K 0.01% 1055

Other funds holding RITM

Freedom Investment Management's RITM Position: Q4 2024 in Review

Freedom Investment Management sold out of Rithm Capital (RITM) in Q4 2024, closing a stake of 20,261 shares — an estimated $230K sold.

Freedom Investment Management first reported a position in RITM in Q1 2018 and held it in 15 quarters. The position peaked at $1.47M in Q3 2018. 480 funds tracked by Wall St. Rank hold RITM as of Q4 2024.

  • Freedom Investment Management reported no remaining Rithm Capital position as of Q4 2024 after selling out during the quarter.
  • Freedom Investment Management sold 20,261 Rithm Capital shares in Q4 2024, an estimated $230K.
  • Freedom Investment Management first reported a position in Rithm Capital in Q1 2018 and held it in 15 quarters.
  • Freedom Investment Management's Rithm Capital position peaked at $1.47M in Q3 2018.
  • 480 funds tracked by Wall St. Rank held Rithm Capital as of Q4 2024.

Based on Freedom Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.